Infection Surveillance Solutions Market By Solution Type (Software and Services), By Infection type (Bloodstream Infection (BSI), Urinary Tract Infection (UTI), Pneumonia (HAP & VAP), Surgical Site Infection (SSI), and Others), By End-user (Hospitals, Outpatient Facilities, and Long-term Care Facilities), Global Analysis to 2023

Infection Surveillance Solutions Market Insights

According to the new report titled " Infection Surveillance Solutions Market By Solution Type (Software and Services), By Infection type (Bloodstream Infection (BSI), Urinary Tract Infection (UTI), Pneumonia (HAP & VAP), Surgical Site Infection (SSI), and Others), By End-user (Hospitals, Outpatient Facilities, and Long-term Care Facilities), Global Analysis to 2023"

The valuation of the Infection Surveillance Solutions market was $571 Million in 2023 and is projected to reach $1310 Million by 2032, at a CAGR of 13.91% from 2021 to 2032.
 

The Infection Surveillance Solutions Market was valued at $571 Million by 2023 and expected to grow at CAGR of 13.91% over forecast period.  Infection surveillance solutions are comprehensive systems used in healthcare settings to monitor, track, and analyze the occurrence and spread of infections. These solutions play a critical role in infection prevention and control efforts, helping healthcare facilities to identify outbreaks early, implement appropriate interventions, and ultimately reduce the risk of healthcare-associated infections (HAIs). Healthcare-associated infections (HAIs) are a significant cause of morbidity and mortality in healthcare settings worldwide. With growing awareness of the impact of HAIs on patient outcomes and healthcare costs, there is an increased emphasis on infection prevention and control measures. Infection surveillance solutions play a crucial role in helping healthcare facilities monitor and manage infections effectively.

Advancements in healthcare technology, including electronic health records (EHRs), health information systems (HIS), and data analytics tools, have enabled the development of sophisticated infection surveillance solutions. These solutions leverage real-time data integration, predictive analytics, and machine learning algorithms to enhance infection detection and response capabilities. With the transition to value-based care models, healthcare providers are under pressure to deliver high-quality care while controlling costs. Infection surveillance solutions contribute to value-based care initiatives by reducing the incidence of HAIs, preventing patient harm, and minimizing healthcare expenditures associated with infection-related complications.

Software held the largest share in the Infection Surveillance Solutions market

By Solution Type (Software and Services) where Software plays a crucial role in the Infection Surveillance Solutions market. Healthcare facilities prioritize patient safety and quality improvement initiatives, driving the demand for infection surveillance software. These solutions enable proactive monitoring of infections, identification of trends, and implementation of targeted interventions to reduce healthcare-associated infections (HAIs) and improve patient outcomes. advancements in healthcare technology, particularly in data analytics, artificial intelligence (AI), and machine learning, have fueled the development of sophisticated infection surveillance software.

These solutions offer real-time monitoring, predictive analytics, and automated alerting capabilities, enhancing the detection and response to infectious disease threats. Infection surveillance software that integrates seamlessly with electronic health record (EHR) systems, laboratory information systems (LIS), and other healthcare IT systems is in high demand. Interoperability enables efficient data exchange, comprehensive patient monitoring, and streamlined workflows for infection control teams. Overall, the demand for infection surveillance software is driven by the imperative to improve patient safety, comply with regulatory requirements, leverage technological advancements, and enhance pandemic preparedness. As healthcare organizations continue to prioritize infection prevention and control, the demand for innovative surveillance software solutions is expected to remain strong.

North America headed the Infection Surveillance Solutions market in 2023

Healthcare facilities in North America are subject to stringent regulatory requirements set forth by agencies such as the Centers for Disease Control and Prevention (CDC), the Centers for Medicare & Medicaid Services (CMS), and various state health departments. Compliance with regulations mandating infection surveillance, reporting, and prevention measures fuels the demand for robust surveillance solutions. North American healthcare organizations prioritize patient safety and quality improvement initiatives. Infection surveillance solutions play a crucial role in these efforts by enabling real-time monitoring, analysis of infection data, and implementation of evidence-based interventions to mitigate healthcare-associated infections (HAIs) and improve patient outcomes. North America is a hub for technological innovation in healthcare, with a robust ecosystem of digital health startups, technology companies, and research institutions. Advancements in data analytics, artificial intelligence (AI), and machine learning drive the development of sophisticated infection surveillance solutions capable of real-time monitoring, predictive analytics, and automated alerting.

 The shift towards value-based care models in North America emphasizes the importance of infection prevention and control in optimizing patient outcomes and reducing healthcare costs. Infection surveillance solutions contribute to value-based care initiatives by minimizing HAIs, preventing patient harm, and enhancing the overall quality of care delivery.

Key market players operating in the market that are

 profiled in the report RL Solutions, GOJO Industries Inc., VigiLANZ Corporation, Cerner Corporation, IBM Corporation, Atlas Medical Software, Becton, Dickinson, and Company, Premier Inc., Wolters Kluwer N.V, Sunquest etc.

Infection Surveillance Solutions Market Report Coverage

Key Players

• Becton
• Dikinson and Company
• Premier Inc.
• Wolters Kluwer N.V.
• Baxter International Inc.
• Gojo Industries
• Inc.
• RL Solutions
• Truven Health Analytics (An IBM Company)
• DEB Group Ltd.
• Hygreen
• Inc.
• Atlas Medical Software.

Infection Surveillance Solutions Market Segmentation

By Type

• Software
• Services

By Application

• Hospitals
• Long-term Care Facilities
• Others

By Geography

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

Research Methodology

The qualitative and quantitative data of the Infection Surveillance Solutions Market is prepared through various research considerations such as subject matter expert advice, primary and secondary research. Primary research leverages valuable information from face-to-face and/or telephonic interviews and surveys, questionnaires, industry expert opinion, KOLs, customers, and others. Primary interviews are conducted regularly with industry experts to create in-depth expert information on the market and to substantiate the existing analysis of the data.

Secondary research done by Verified Market Reports research team through various sources such as

• Company websites, annual reports, financial reports, investor presentations and SEC filings
• Internal and external proprietary databases, relevant patent, and regulatory databases
• National government documents, statistical databases, and market reports
• News articles, press releases and web-casts specific to the companies operating in the market
• Paid database

Verified Market Reports contacted various key opinion leaders from the same industry, who are top and mid-level executives from top companies as well as executives (marketing heads, regional heads) from End users to collect information/data such as the dominance of particular brand in each country as well as overall region, pricing of services and products.

The data for total sales was determined through primary research in each of the countries by interviewing key opinion leaders which included insights from

• C-Level Executives
• Marketing Manager, Brand Manager, Product Manager
• Sales Manager, Sales Officer, Regional Sales Manager, Country Manager
• Procurement Manager
• Production Manager
• Technical Personnel
• Distributors